Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17882020 | 0.94 | ALDH1A1 (0.44) | LMNAMAPTMAPK1ALDH1A1CHRM1 | |
| SCHEMBL17878555 | 0.90 | LMNA (0.40) | LMNAMAPTMAPK1ALDH1A1CHRM1 | |
| SCHEMBL17860698 | 0.88 | LMNA (0.39) | LMNAMAPTMAPK1ALDH1A1CHRM1 | |
| SCHEMBL5962564 | 0.84 | LMNA (0.56) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL5962581 | 0.84 | LMNA (0.56) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL14991338 | 0.82 | CHRM1 (0.37) | LMNAALDH1A1CHRM1AKR1A1CHRM3 | |
| SCHEMBL24593948 | 0.82 | LMNA (0.53) | LMNAMAPTMAPK1ALDH1A1TDP1 | |
| SCHEMBL17882025 | 0.82 | LMNA (0.48) | LMNAMAPTMAPK1ALDH1A1TDP1 | |
| SCHEMBL21695014 | 0.82 | MGAM (0.41) | LMNACHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL28084580 | 0.80 | TRPV1 (0.44) | LMNAMAPTALDH1A1CHRM1AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723750-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | CLAP CO LTD (KR) | 2022-08-10 | — | — | EP | disclosed |
| EP-2751855-B1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2020-10-28 | — | — | EP | disclosed |
| EP-2751855-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2014-07-09 | — | — | EP | disclosed |
| EP-2723750-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2014-04-30 | — | — | EP | disclosed |
| WO-2013030325-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS AND COMPOSITIONS, COMPRISING DIKETOPYRROLOPYRROLE OLIGOMERS | BASF SE (DE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2012175530-A1 | DIKETOPYRROLOPYRROLE OLIGOMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2012-12-27 | — | — | WO | disclosed |
| EP-0962499-B2 | Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles | CIBA SC HOLDING AG (CH) | 2008-03-05 | — | — | EP | disclosed |
| US-7326793-B2 | From a pyrrolidinone compound; coloring high molecular weight material | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-02-05 | — | — | US | disclosed |
| EP-1425282-B1 | PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLES | CIBA SC HOLDING AG (CH) | 2007-03-21 | — | — | EP | disclosed |
| US-7186847-B2 | From a pyrrolidinone compound; coloring high molecular weight material | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1436296-B1 | PROCESS FOR THE DIRECT PREPARATION OF PYRROLO[3,4-C]PYRROLES | CIBA SC HOLDING AG (CH) | 2006-03-22 | — | — | EP | disclosed |
| US-20040249162-A1 | From a pyrrolidinone compound; coloring high molecular weight material | BASF SE (DE) | 2004-12-09 | — | — | US | disclosed |
| US-20040171847-A1 | From a pyrrolidinone compound; coloring high molecular weight material | CIBA SPECIALTY CHEMICALS CORP. | 2004-09-02 | — | — | US | disclosed |
| EP-1436296-A2 | PROCESS FOR THE DIRECT PREPARATION OF PYRROLO 3,4-C]PYRROLES | Ciba SC Holding AG (CH) | 2004-07-14 | — | — | EP | disclosed |
| EP-1425282-A2 | PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLES | Ciba SC Holding AG (CH) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003022848-A2 | PROCESS FOR THE PREPARATION OF DIKETOPYRROLOPYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022847-A2 | PROCESS FOR THE DIRECT PREPARATION OF PYRROLO[3,4-C]PYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-20 | — | — | WO | disclosed |
| EP-0962499-B1 | Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles | CIBA SC HOLDING AG (CH) | 2003-03-05 | — | — | EP | disclosed |
| EP-0962499-A2 | Direct preparation of pigmentary pyrrolo-(3,4-C)pyrroles | Ciba SC Holding AG (CH) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249162-A1 | From a pyrrolidinone compound; coloring high molecular weight material | PAXBP1, PAX3, PPOX | LMNA 4175/4885MAPT 1138/4885MAPK1 875/4885 |
| US-20040171847-A1 | From a pyrrolidinone compound; coloring high molecular weight material | MKI67, PAH, PKLR | LMNA 3162/4885MAPT 2491/4885MAPK1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.